Add BrightSurf on Google Email

New mobile health technology for sleep apnea care to address individual patient needs

Researchers developed an app to track CPAP use, sleep patterns, and other health metrics to provide a new adherence metric that aligns therapy with individual need. This tool can help patients and providers deliver more effective sleep apnea treatment by tracking progress toward a personalized dose of therapy.

SourceUniversity of Chicago Medical Center·JournalJournal of Medical Internet Research·DateDec 5, 2022

Study links genetic variant to digestive disturbances in patients with Chagas disease

Researchers identified a genetic variant linked to digestive disturbances in patients with Chagas megaesophagus, a disorder characterized by esophageal dilation and loss of motility. The study suggests that increased interferon-gamma production leads to mitochondrial dysfunction, contributing to the development of the disease.

Diet can lower risk of cardiovascular disease by 10 percent, study shows

A new study published in the American Journal of Cardiology found that a healthy diet can reduce the risk of cardiovascular disease by up to 10%. The Dietary Approaches to Stop Hypertension (DASH) diet, which emphasizes whole grains, lean proteins, and fruits and vegetables, showed additional benefits for women and black adults compare...

SourceBeth Israel Deaconess Medical Center·JournalThe American Journal of Cardiology·DateNov 29, 2022

The Green Mediterranean diet reduces twice as much visceral fat as the Mediterranean diet and 10% more than a healthy diet

A recent clinical trial found that the Green Mediterranean diet reduced visceral adipose tissue by 14%, outperforming both the traditional Mediterranean diet and a healthy diet. The new diet incorporates dietary polyphenols and lower red meat intake, resulting in significant weight loss benefits.

SourceBen-Gurion University of the Negev·JournalBMC Medicine·TypeRandomized controlled/clinical trial·DateNov 28, 2022

Risk of heart disease can be predicted with simple eye test through artificial intelligence algorithm, research involving London's Kingston University finds

A new study using artificial intelligence has found that a simple eye test can accurately predict the risk of heart disease. The researchers developed an algorithm that can analyze retinal images to assess cardiovascular health, providing a non-invasive alternative to traditional risk scores.

SourceKingston University·JournalBritish Journal of Ophthalmology·TypeObservational study·DateNov 24, 2022

Longest follow-up of patients with early breast cancer shows radiotherapy does not improve survival after 30 years

A 30-year follow-up study of patients with early breast cancer found that radiotherapy does not improve overall survival rates after 10 years but reduces the risk of recurrence in the same breast. The study's findings challenge traditional concepts of long-term anti-cancer benefits of radiotherapy.

SourceEuropean Organisation for Research and Treatment of Cancer·TypeRandomized controlled/clinical trial·DateNov 17, 2022

Blinding eye disease strongly associated with serious forms of cardiovascular disease

A new study from Mount Sinai Hospital finds a strong association between age-related macular degeneration and severe forms of heart disease, including heart failure, heart attacks, and stroke. The study highlights the importance of increased screening for eye disorders to diagnose undetected heart disease.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalBMJ Open Ophthalmology·TypeImaging analysis·DateNov 17, 2022

Adversity in childhood is linked to increased risk of heart and blood vessel diseases in early adulthood

A large study found that children who experienced adversity, including serious family illness or death, poverty, neglect, or dysfunctional relationships, are at increased risk of developing cardiovascular disease in early adulthood. The study, published in the European Heart Journal, followed nearly 1.3 million children and found a 60%...

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·TypeObservational study·DateNov 14, 2022

Bariatric surgery decreases risk of heart disease

A Rutgers study of 86,964 adults with obesity and NAFLD found that bariatric surgery reduced the risk of major cardiovascular events by 49% compared to nonsurgical care. This is significant because heart disease is a leading cause of death in the US, and NAFLD can lead to liver damage and inflammation.

SourceRutgers University·JournalJAMA Network Open·TypeData/statistical analysis·DateNov 14, 2022

Clinical trial finds novel therapy markedly reduced lipoprotein(a) levels in people with cardiovascular disease

Researchers at Brigham and Women's Hospital found that olpasiran, a small interfering RNA drug, significantly reduces lipoprotein(a) levels in patients with established cardiovascular disease. The treatment was associated with minimal serious side effects apart from injection site reactions.

SourceBrigham and Women's Hospital·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateNov 6, 2022

Breast cancer survivorship doubles

A study published in the Journal of the National Comprehensive Cancer Network found that breast cancer survivorship has doubled among Canadian women, with 2.1% of adult females diagnosed with breast cancer and 86% surviving by 2022. The prevalence varies by age group, with senior women having a higher rate of survival.

SourceUniversity of Toronto·JournalJournal of the National Comprehensive Cancer Network·TypeData/statistical analysis·DateNov 3, 2022

ACC, AHA issue aortic disease guideline

The new guideline covers key aspects of aortic disease diagnosis and management, including surgical intervention considerations, consistent imaging practices, genetic and familial screenings. The ACC and AHA emphasize the importance of a multidisciplinary team in providing optimal care for patients with aortic disease.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·TypeLiterature review·DateNov 2, 2022

Four prospective, multicenter studies support use of drug-coated balloons over bare metal stents in treating femoropopliteal lesions

A new study published in Journal of the American College of Cardiology found that drug-coated balloons outperformed bare metal stents in treating femoropopliteal lesions. The research showed improved 12-month patency and freedom from clinically driven reintervention and major adverse events with drug-coated balloons.

SourceUniversity Hospitals Cleveland Medical Center·JournalJournal of the American College of Cardiology·DateNov 1, 2022

New genetic research by UMass Amherst advances understanding of internal mechanisms of biological clocks

The study reveals that a genetic mutation can accelerate the body's internal clock, leading to improved adjustment to shift work schedules. The findings have implications for understanding the health consequences of circadian misalignment and developing medical treatments.

SourceUniversity of Massachusetts Amherst·JournalProceedings of the National Academy of Sciences·TypeObservational study·DateOct 20, 2022

NIH-supported study finds racial disparities in advanced heart failure treatment

A recent NIH-supported study found that Black adults treated at advanced heart failure centers received potentially life-changing therapies, such as transplants and heart pumps, about half as often as white adults due to racial bias. The researchers also suggest that unconscious bias and overt racism may be driving these disparities.

SourceNIH/National Heart, Lung and Blood Institute·JournalCirculation Heart Failure·DateOct 19, 2022

Genetic testing helps detect children likely to have heart failure and require a transplant

Researchers have developed genetic testing to diagnose cardiomyopathy in children, identifying those at risk of heart failure and requiring a transplant. The test provides precise clinical diagnosis, enabling targeted treatment options and reducing the need for life-threatening interventions.

SourceCentenary Institute·JournalCirculation Genomic and Precision Medicine·TypeExperimental study·DateOct 12, 2022

Thirdhand smoke can trigger skin diseases

A UC Riverside-led study found that acute THS exposure initiates mechanisms of inflammatory skin disease and elevates urinary biomarkers of oxidative harm. The researchers discovered elevated molecular biomarkers in blood associated with early-stage activation of contact dermatitis, psoriasis, and other skin conditions.

SourceUniversity of California - Riverside·JournalEBioMedicine·TypeExperimental study·DateOct 11, 2022

Family Heart Foundation study shows some children with homozygous familial hypercholesterolemia miss out on decades of life-saving treatment

Children with homozygous familial hypercholesterolemia are diagnosed earlier and have higher untreated LDL-C levels than adults, while those not identified early miss out on decades of life-saving treatment. This study emphasizes the need for universal screening to identify children with HoFH or heterozygous familial hypercholesterolemia.

Cleveland Clinic researchers identify diabetes drug metformin as potential atrial fibrillation treatment in collaborative research

Researchers found that metformin targeted 30 genes associated with atrial fibrillation, showing direct effects on gene expression for eight. The study suggests metformin may be a promising candidate for treating atrial fibrillation due to its potential to reduce the risk of complications such as stroke and heart failure.

SourceCleveland Clinic·JournalCell Reports Medicine·DateOct 11, 2022

Particle radioactivity linked to pollution-associated heart attack and stroke death

Particle radioactivity from radon in air pollution increases toxicity and risk of death from cardiovascular disease, especially from heart attack and stroke. Researchers used spatiotemporal predictions to estimate exposure and found that higher gross beta-activity levels increased the risk of death from these conditions.

SourceAmerican Heart Association·JournalJournal of the American Heart Association·DateOct 5, 2022